Antifungal activity of histatin-5 against non-albicans Candida species

Oral Microbiology and Immunology

Volumn 16, Issue 4, 2001, Pages 250-252

  Nikawa, H ^a   Jin, C ^a   Fukushima, H ^a   Makihira, S ^a   Hamada, T ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Antifungal activity; Candida; Histatin 5; Saliva

Indexed keywords

ANTIFUNGAL AGENT; HISTATIN 5; PROTEINASE INHIBITOR; SALIVA PROTEIN;

ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL COUNT; CANDIDA; CLASSIFICATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; MOUTH; STATISTICS;

ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; CANDIDA; COLONY COUNT, MICROBIAL; HUMANS; MOUTH; PROTEASE INHIBITORS; SALIVARY PROTEINS; STATISTICS;

EID: 0034954520     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-302X.2001.160409.x     Document Type: Article

References (22)

1. Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidaemia cases over a 5 year period
2. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans
3. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides
4. One-step purification of histidine-rich polypeptides form human parotid saliva and determination of anticandidal activity
5. Emergence of Candida parapsilosis as the predominant species causing candidemia in children
6. Longitudinal study of parotid saliva in HIV-1 infection
7. Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation
8. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei
9. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin
10. An epidemiological study of Candida species infection in cancer patients using genetic fingerprinting and morphotyping
11. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans
12. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans
13. Salivary histatin 5: Dependence of sequence, chain length, and helical conformation for candidacidal activity
14. Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates
15. Laboratory diagnosis of oral candidosis
16. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1
17. The emerging fungal threat
18. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans
19. The in vitro susceptibility of Candida species to lysozyme
20. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
21. Importance of Candida species other than C. albicans as pathogens in oncology patients
22. Anticandidal activity of major human salivary histatins